Neuphoria Therapeutics Inc. (NEUP)

NASDAQ: NEUP · Real-Time Price · USD

Compare

4.030

+0.035 (0.88%)

At close: Feb 6, 2026, 4:00 PM EST

3.945

-0.085 (-2.11%)

After-hours: Feb 6, 2026, 5:05 PM EST

Neuphoria Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	13.65	14.21	12.61	12.1	23.13	21.37
Cash & Short-Term Investments	13.65	14.21	12.61	12.1	23.13	21.37
Cash Growth	68.88%	12.71%	4.17%	-47.66%	8.23%	576.06%
Accounts Receivable	-	-	-	-	-	0.14
Other Receivables	0	0.01	0.13	0.43	4.67	0.7
Receivables	0	0.01	0.13	0.43	4.67	0.85
Prepaid Expenses	0.22	0.74	0.46	0.8	1.01	0.65
Restricted Cash	0.08	0.08	-	-	-	0.33
Total Current Assets	13.95	15.04	13.19	13.33	28.81	23.19
Property, Plant & Equipment	0.08	0.11	0.22	0.33	0.46	0.65
Goodwill	8.67	8.64	8.69	8.69	8.87	9.3
Other Intangible Assets	4.64	4.8	5.47	6.13	6.78	7.46
Other Long-Term Assets	-	-	0.08	0.08	0.08	0.09
Total Assets	27.34	28.59	27.65	28.56	45	40.68
Accounts Payable	1.37	1.15	2.24	1.44	1.07	0.77
Accrued Expenses	3.6	2.88	1.39	1.19	1.13	0.87
Short-Term Debt	0.03	0.03	0.03	-	-	-
Current Portion of Leases	0.09	0.12	0.12	0.11	0.11	0.13
Other Current Liabilities	0.03	0.04	0.04	-	-	-
Total Current Liabilities	5.12	4.22	3.83	2.74	2.31	1.77
Long-Term Leases	-	-	0.12	0.24	0.37	0.52
Pension & Post-Retirement Benefits	-	-	-	-	0.01	0.01
Long-Term Deferred Tax Liabilities	0.46	0.5	0.96	1.1	1.24	1.38
Other Long-Term Liabilities	9.25	4.87	5.25	2.47	1.86	1.32
Total Liabilities	14.83	9.59	10.16	6.55	5.79	5
Common Stock	0	0	0	-	149.99	142.59
Additional Paid-In Capital	203.56	200.19	198.48	187.55	-	-
Retained Earnings	-188.25	-178.35	-177.98	-162.48	-119.41	-115.49
Comprehensive Income & Other	-2.8	-2.85	-3.01	-3.06	8.63	8.58
Shareholders' Equity	12.51	19	17.49	22.01	39.21	35.69
Total Liabilities & Equity	27.34	28.59	27.65	28.56	45	40.68
Total Debt	0.12	0.15	0.27	0.35	0.48	0.65
Net Cash (Debt)	13.53	14.06	12.34	11.75	22.65	20.72
Net Cash Growth	72.09%	13.99%	4.99%	-48.12%	9.32%	-
Net Cash Per Share	7.28	8.66	14.82	0.01	0.02	0.03
Filing Date Shares Outstanding	5.38	2.36	3,118	1,469	1,353	1,008
Total Common Shares Outstanding	2.36	1.98	2,385	1,469	1,353	1,008
Working Capital	8.83	10.82	9.36	10.59	26.49	21.42
Book Value Per Share	5.31	9.60	0.01	0.01	0.03	0.04
Tangible Book Value	-0.8	5.56	3.33	7.19	23.57	18.93
Tangible Book Value Per Share	-0.34	2.81	0.00	0.00	0.02	0.02
Machinery	-	-	-	-	-	0.08

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q